Status:
COMPLETED
A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to look at different ways to help patients follow their anti-HIV medication schedules. It is very important that HIV-positive patients take their anti-HIV medications cor...
Detailed Description
Adherence to antiretroviral (AR) therapy has become increasingly important in the management of HIV infection. Adherence to AR regimens is thought to be a critical factor in maintaining therapeutic dr...
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Are enrolling in a qualifying CPCRA AR therapeutic study. Currently, the FIRST and MDR-HIV studies are the only qualifying protocols.
Exclusion Criteria
Patients will not be eligible for this study if they:
- Are enrolling at a clinic site that is unable to participate in this study for some reason.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
June 1 2003
Estimated Enrollment :
1248 Patients enrolled
Trial Details
Trial ID
NCT00001129
End Date
June 1 2003
Last Update
October 1 2013
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Consortium / UCSF
San Francisco, California, United States, 94110
2
Virginia Cafaro M.D.
San Francisco, California, United States, 94110
3
Denver CPCRA / Denver Public Hlth
Denver, Colorado, United States, 80204
4
Univ Hosp Infectious Diseases Clinic
Denver, Colorado, United States, 80204